<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1715">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03084549</url>
  </required_header>
  <id_info>
    <org_study_id>CHD065-16</org_study_id>
    <nct_id>NCT03084549</nct_id>
  </id_info>
  <brief_title>Study of the Analgesic Effect of the Perineal Infiltration of Ropivacaine 0.75% Versus Placebo in Post-episiotomy Perineal Pain</brief_title>
  <acronym>ROPISIO</acronym>
  <official_title>Study of the Analgesic Effect of the Perineal Infiltration of Ropivacaine 0.75% Versus Placebo in Post-episiotomy Perineal Pain: a Randomized, Double-blind Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Departemental Vendee</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Departemental Vendee</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Episiotomy is a common obstetric gesture (20 to 30% of deliveries by the low route). In
      postpartum, perineal pains associated with episiotomy are common, about 70% on D7 and
      persistent 13% at 5 months. Most studies of obstetrical analgesia have focussed on pain
      during labor or following a caesarean section. The perineal pain associated with the
      realization of an episiotomy has been much less studied and often undervalued.

      Local ropivacaine has shown its effectiveness in the reduction of postoperative pain in many
      indications (wall surgery, hemorrhoidectomy, infiltration of trocar scars during
      laparoscopy). This product has the advantage of being well tolerated, easy access and
      administration. Three recent studies compared the post-episiotomy analgesic efficacy of
      local ropivacaine versus lidocaine versus placebo and lidocaine versus no infiltration. Two
      of these studies showed statistically significant results. However, they focused on the
      results at 24 and 48 hours and did not evaluate the analgesic efficacy in the medium and
      long term.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2017</start_date>
  <completion_date type="Anticipated">September 2017</completion_date>
  <primary_completion_date type="Anticipated">April 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Participant, Care Provider, Investigator, Outcomes Assessor</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Compare the analgesic efficacy of ropivacaine 0.75 mg / ml infusion versus placebo (physiological saline) in patients with right mid-lateral episiotomy during postpartum D7 delivery.</measure>
    <time_frame>7 days after episiotomy</time_frame>
    <description>Digital pain scale</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">272</enrollment>
  <condition>Episiotomy</condition>
  <arm_group>
    <arm_group_label>Ropivacaïne</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Administration of Ropivacaïne</intervention_name>
    <description>Administration of Ropivacaïne in the margins of the episiotomy</description>
    <arm_group_label>Ropivacaïne</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Administration of placebo</intervention_name>
    <description>Administration of placebo in the margins of the episiotomy</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Major Patient (≥ 18 years)

          -  Term ≥ 37 weeks of amenorrhea

          -  Right medio-lateral episiotomy performed for medical need

          -  Delivery of a single fetus in a cephalic presentation with or without instrumental
             extraction

          -  Delivery under epidural anesthesia

          -  Patient to be monitored over 6 months of study

          -  Patient in ability to understand protocol

          -  Patient having given consent and signed informed consent

          -  Patient with social coverage

        Exclusion Criteria:

          -  Hypersensitivity or known allergy to Ropivacaine or to other amide-linked local
             anesthetics or to any of the excipients

          -  General contraindication specific to local anesthesia, irrespective of the local
             anesthetic used

          -  Contraindication for Ropivacaine- Obstetric paracervical anesthesia

          -  Hypovolemia

          -  Weight &lt;50 kg

          -  Contra-indication or refusal of the epidural

          -  Poor understanding of the French language

          -  Substance addiction.

          -  Chronic pain syndrome.

          -  Severe hepatic or renal impairment.

          -  Acute porphyria.

          -  Caesarean section programmed.

          -  Tear of the 3rd degree according to the associated French classification.

          -  Refusal to participate in the study

          -  Patient under tutelage, curatorship, or deprived of liberty
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guillaume DUCARME</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHD Vendée</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chloé MOREAU</last_name>
    <phone>0251446572</phone>
    <email>chloe.moreau@chd-vendee.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre Hospitalier Departemental Vendee</name>
      <address>
        <city>La Roche sur Yon</city>
        <zip>85925</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Guillaume DUCARME</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Nantes</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Norbert WINER</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 22, 2017</lastchanged_date>
  <firstreceived_date>March 15, 2017</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Analgesics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
